Press Releases

Abbott and Tandem Diabetes Care Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems

Abbott and Tandem Diabetes Care announced that they have finalized an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's world-leading1 continuous glucose monitoring (CGM) technology with Tandem's innovative insulin delivery systems to provide more options for...

PCI Pharma Services Announces Completion of Biotech Center of Excellence in Philadelphia and Expansions to Biotech Capabilities in Europe

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced the completion of the expansion of its new Biotech Center of Excellence in Philadelphia, Pennsylvania, a major investment that will represent the new U.S. biologics...

Tiziana announces agreement with STC Biologics for manufacturing of TZLS-501

Tiziana Life Sciences plc, a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, announces the execution of an agreement with STC Biologics, Inc. for GMP manufacturing of TZLS-501, an anti-IL-6 receptor (anti-IL-6R) monoclonal antibody...

CPhI Festival of Pharma to support and lead global pharma industry forward with new digital experience in 2020

Over recent weeks and months, CPhI Worldwide – organised by Informa Markets – has been in constant discussions with key industry stakeholders and partners to stay abreast of the challenges and complexities facing the different segments of the Pharma...

India’s 1st COVID-19 Vaccine -COVAXIN, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials

Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech....

Bormioli Pharma invests in Type I glass vial production for injectable medicines and vaccines

The company invested more than 50 million euros in the last months for improving its production platform, including a brand-new glass furnace in Bergantino, the upgrade of the San Vito al Tagliamento glass production, as well as the acquisition...

Malvern Panalytical and Concept Life Sciences launch Amplify Analytics

Malvern Panalytical (Malvern, UK) and Concept Life Sciences (Cheshire, UK) have jointly launched Amplify Analytics - a new range of highly flexible services designed to help pharmaceutical companies rapidly identify those drug candidates that meet bioavailability and processability requirements,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read